Medline shareholders price $2.13 billion secondary offering with $200 million concurrent repurchase
Medline Inc. announced that affiliated shareholders will sell 60 million Class A shares at $35.50 each, generating $2.13 billion. The underwriters may, within a 30‑day period, purchase up to an additional 9 million shares. The transaction is slated to close on November 23 2026, and Medline will buy back $200 million of stock from the sellers, receiving no proceeds itself.
Why it matters
The large secondary offering could increase the share supply and pressure the price, while the $200 million buy‑back may partially offset dilution. Investors should note the expected closing date and the optional extra shares that could further affect supply.
Key facts
- 1The offering price is $35.50 per share. investing.com
- 260 million Class A shares are being sold. investing.com
- 3The sale will raise $2.13 billion. seekingalpha.com
- 4Underwriters have a 30‑day right to purchase up to 9 million additional shares. investing.com
- 5The closing is scheduled for November 23 2026. investing.com
- 6Medline will repurchase $200 million of stock from the selling shareholders. investing.com
Summary written by AlphAI AI Desk from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.